National Eye Institute Biorepository for Retinal Diseases
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- National Eye Institute (NEI)
- Study ID
- NCT01496625
- Status
- Recruiting
Conditions
- Age-Related Macular Degeneration
- Diabetic Retinopathy
- Retinal Disease
- Retinal Vein Occlusion
- Von Hippel-Lindau Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 120 Years
- Healthy Volunteers
- Accepted
Study Details
Background: \- To understand diseases of the retina and the eye, information is needed about people with and without such diseases. Researchers want to study these people and follow them over time. They also want to study body tissues and blood to understand the nature of eye disease. Studying genes, cells, and tissues may help them understand why some people get eye problems and others do not, or why some people respond to treatment while others do not. Researchers want to collect physical samples and personal data to develop a National Eye Institute database. Objectives: \- To collect health information and blood and tissue samples from people with and without eye diseases, to be used in research studies. Eligibility: * Individuals at least 2 years of age with different types of eye disease. * Healthy volunteers with no history of eye disease. Design: * Participants may be recruited from National Eye Institute studies or may be referred from other sources. * Participants will be screened with a physical exam and medical history. They will also have a full eye exam. Questions will be asked about family medical history, especially about eye disease. * Blood samples will be collected. Other samples, such as saliva, tears, hair, stool, and urine, may be collected as needed. Adult participants may also provide a skin sample. * Tissue or fluid from eye collected as part of eye care or treatment may also be added to the database. * No treatment will be provided as part of this study.
Key Dates
- Start date
- Jun 18, 2012
- Status verified
- Mar 2026
Study Design
- Enrollment
- 650 participants (estimated)
Arms
- Arm: Cohort 1Participants with age-related macular degeneration (AMD), diabetic retinopathy, and other retinal diseases.
- Arm: Cohort 2Participants without any retinal diseases.
Primary Outcome Measure
The intent is to collect data on a variety of phenotypic parameters and to store biospecimens in a manner that permits a broad array of potential testing and experimentation in the future. [ Time Frame: Ongoing ]
Central Contacts
- Sheena Jose(301) 402-7635
- Tiarnan DL Keenan, M.D.(301) 451-6330
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 |
Find similar trials in Bethesda, MD
Related Studies
- Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 GeneRecruiting · National Eye Institute (NEI) · Bethesda, Maryland
- Cell Collection to Study Eye DiseasesRecruiting · National Eye Institute (NEI) · Bethesda, Maryland
- Inherited Retinal Degenerative Disease RegistryRecruiting · Foundation Fighting Blindness · Columbia, Maryland
- Optical Coherence Tomography Angiography in Subjects With Retinal Vascular DiseaseRecruiting · Johns Hopkins University · Baltimore, Maryland